Abstract
Despite our increasing characterization of the molecular basis for many primary immunodeficiency states, significant heterogeneity in clinical and immunological phenotype exists. Epigenetic alterations have been implicated in the pathogenesis of immune dysregulation and may provide a unique paradigm to help us understand the phenotypic heterogeneity in primary immunodeficiency. The occurrence of X-linked thrombocytopenia (XLT) and Wiskott–Aldrich syndrome (WAS) in monozygotic twins is a rare occurrence which allows for the exploration of epigenetic alterations and associated phenotypic heterogeneity. We describe a pair of monozygotic twin brothers with a missense mutation in the WAS gene consistent with reduced expression of the WAS protein, a XLT phenotype, and a good prognosis. Despite this genotype and anticipated mild phenotype in both twins, a discordant phenotype has evolved in which one twin demonstrates asymptomatic thrombocytopenia and the other symptomatic thrombocytopenia, infectious complications, and autoimmunity. Characterization of the potential epigenetic contribution to the spectrum of XLT and WAS is described and the implications of these findings are discussed.
References
Notarangelo LD. Primary immunodeficiencies. J Allergy Clin Immunol. 2010;125:S182–94.
Lim MS, Elenitoba-Johnson K. The molecular pathology of primary immunodeficiencies. J Mol Diagn. 2004;6:59–83.
Morange M. The relations between genetics and epigenetics: a historical point of view. Ann N Y Acad Sci. 2002;981:50–60.
Holiday R. Epigenetics: a historical overview. Epigenetics. 2006;1:76–80.
Geha RS, Notarangelo LD, Casanova J-L, et al. Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee. J Allergy Clin Immunol. 2007;120:776–94.
Buckley RH. Variable phenotypic expression of mutations in genes of the immune system. J Clin Invest. 2005;115:2974–6.
Meda F, Folci M, Baccarelli A, et al. The epigenetics of autoimmunity. Cell Mol Immunol. 2011;8:226–36.
Hewagama A, Richardson B. The genetics and epigenetics of autoimmune disease. J Autoimmun. 2009;33:3–11.
Erlich M, Sanchez C, Shao C, et al. ICF, an immunodeficiency syndrome: DNA methyltransferase 3B involvement, chromosome anomalies, and gene dysregulation. Autoimmunity. 2008;41:253–71.
Erlich M. The ICF syndrome, a DNA methyltransferase 3B deficiency and immunodeficiency disease. Clin Immunol. 2003;109:17–28.
Bosticardo M, Marangoni F, Aiuti A, et al. Recent advances in understanding the pathophysiology of Wiskott–Aldrich syndrome. Blood. 2009;113:6288–95.
Ochs HD, Filipovich AH, Veys P, et al. Wiskott–Aldrich syndrome: diagnosis, clinical and laboratory manifestations, and treatment. Biol Blood Marrow Transplant. 2009;15:84–90.
Albert MH, Bittner TC, Nonoyama S, et al. X-linked thrombocytopenia (XLT) due to WAS mutations: clinical characteristics, long-term outcome, and treatment options. Blood. 2010;115:3231–8.
Gulacsy V, Freiberger T, Shcherbina A, et al. Genetic characteristics of eighty-seven patients with the Wiskott–Aldrich syndrome. Mol Immunol. 2011;48:788–92.
Thompson LJ, Lalloz M, Layton DM. Unique and recurrent WAS gene mutation in Wiskott–Aldrich syndrome and X-linked thrombocytopenia. Blood Cells Mol Dis. 1999;25:218–26.
Zhu Q, Watanabe C, Liu T, et al. Wiskott–Aldrich syndrome/X-linked thrombocytopenia: WASP gene mutations, protein expression, and phenotype. Blood. 1997;90:2680–9.
Jin Y, Mazza C, Christie JR, et al. Mutations of the Wiskott–Aldrich syndrome protein (WASP): hotspots, effect on transcription, and translation and phenotype/genotype correlation. Blood. 2004;104:4010–9.
Imai K, Morio T, Zhu Y, et al. Clinical course of patients with WASP gene mutations. Blood. 2004;103:456–64.
Schindelhauer D, Weiss M, Hellebrand H, et al. Wiskott–Aldrich syndrome: no strict genotype–phenotype correlations but clustering of missense mutations in the amino-terminal part of the WASP gene product. Hum Genet. 1996;98:68–76.
Fillat C, Espanol T, Oset M, et al. Identification of WASP mutations in 14 Spanish families with Wiskott–Aldrich syndrome. Am J Med Genet. 2001;100:116–21.
Yu GP, Chiang D, Song SJ, et al. Regulatory T cell dysfunction in subjects with common variable immunodeficiency complicated by autoimmune disease. Clin Immunol. 2009;131:240–53.
Nadeau KC, Callejas A, Wong WB, et al. Idiopathic neutropenia of childhood is associated with Fas/FasL expression. Clin Immunol. 2008;129:438–47.
Nguyen KD, Vanichsarn C, Fohner A, et al. Selective deregulation in chemokine signaling pathways of CD4 + CD25(hi)CD127(lo)/(−) regulatory T cells in human allergic asthma. J Allergy Clin Immunol. 2009;123:933–9.
Forsyth K, Seshadri R, Matthews C, Heddle R. Wiskott–Aldrich in identical twins: abnormality of CD4 and CD8 positive lymphocytes. Aust NZ J Med. 1988;18:73–6.
Xie H, Wang M, de Andrade A, et al. Genome-wide quantitative assessment of variation in DNA methylation patterns. Nucleic Acids Res. 2011;39:4099–108.
Ushijima T, Watanabe N, Okochi E, et al. Fidelity of the methylation pattern and its variation in the genome. Genome Res. 2003;13:868–74.
Pearce EL. Making sense of inflammation, epigenetics, and memory CD8+ T-cell differentiation in the context of infection. Immunol Rev. 2006;211:197–202.
McCall CE, Yoza B, Liu T, et al. Gene-specific epigenetic regulation in serious infections with systemic inflammation. J Innate Immun. 2010;2:395–405.
Csoka AB, Szyf M. Epigenetic side-effects of common pharmaceuticals: a potential new field in medicine and pharmacology. Med Hypotheses. 2009;73:770–80.
Copeland RA, Olhava EJ, Scott MP. Targeting epigenetic enzymes for drug discovery. Curr Opin Chem Biol. 2010;14:505–10.
Mack GS. Epigenetic cancer therapy makes headway. JNCI. 2006;98:1443–4.
Acknowledgments
We would also like to acknowledge the assistance of David Lewis, MD, Michael Jeng, MD, Kenneth Weinberg, MD, and Stephen Mao, PhD for their assistance in the preparation of this manuscript.
Author information
Authors and Affiliations
Corresponding author
Additional information
David Buchbinder and Kari Nadeau are co-first authors.
Rights and permissions
About this article
Cite this article
Buchbinder, D., Nadeau, K. & Nugent, D. Monozygotic Twin Pair Showing Discordant Phenotype for X-linked Thrombocytopenia and Wiskott–Aldrich Syndrome: a Role for Epigenetics?. J Clin Immunol 31, 773–777 (2011). https://doi.org/10.1007/s10875-011-9561-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10875-011-9561-3